Zetia Pay-For-Delay MDL Should Press On, Magistrate Says
Zetia buyers have sufficiently alleged that Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. kept a generic of the cholesterol medication off the market using a so-called pay-for-delay agreement, a Virginia...To view the full article, register now.
Already a subscriber? Click here to view full article